NCT00631111已完成3 期
Ibuprofen 400 mg Effervescent Tablet Dental Pain Study II
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 270 人开始时间: 2007年11月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 270
- 主要终点
- Sum of pain relief and pain intensity difference scores
研究概览
简要总结
Evaluation of the efficacy and safety of a single dose of an ibuprofen effervescent tablet in the treatment of pain following third molar extraction in comparison to single doses of placebo, standard ibuprofen tablets, and effervescent aspirin plus vitamin C tablets.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 16 Years 至 40 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
干预措施: effervescent ibuprofen tablets (Drug)
2
Active Comparator
干预措施: effervescent Aspirin plus Vitamin C tablets (Drug)
3
Active Comparator
干预措施: ibuprofen tablets (Drug)
4
Placebo Comparator
干预措施: placebo (Drug)
结局指标
主要结局
Sum of pain relief and pain intensity difference scores
时间窗: 8 hours
次要结局
- Time to meaningful pain relief(8 hours)
研究者
相似试验
已完成
3 期
Multiple Dose Dental Pain Study Of Ibuprofen Extended ReleasePainNCT01266161Pfizer106
已完成
3 期
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental PainPainNCT01098747Pfizer335
Unknown
3 期
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.IbuprofenNonsteroidal Anti-inflammatory DrugIntravenousInjectablePainAnalgesicNCT04429282Yi Feng, MD396
已完成
3 期
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental PainPainNCT01216163Pfizer218
已完成
2 期
Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental PainPainNCT00913627Pfizer196